<i>ERCC1</i> and <i>ERCC2</i> Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer.

Pharmaceutics · 2024 · PMC11434779 · PMID 39339159

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Lastly, ERCC1 rs11615 and ERCC2 rs1799793 associations with survival and toxicity, respectively, did not reach statistical significance according to the Bonferroni correction criteria.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.